Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...

New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...

Panelists discuss exciting phase 3 trial data on a novel selective phosphodiesterase inhibitor that elevates intracellular ...

Iptacopan targets one of the major proteins involved in the enzymes of the alternative pathway of complement, explains Carla ...